301 related articles for article (PubMed ID: 17405850)
1. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.
Feuillan P; Calis K; Hill S; Shawker T; Robey PG; Collins MT
J Clin Endocrinol Metab; 2007 Jun; 92(6):2100-6. PubMed ID: 17405850
[TBL] [Abstract][Full Text] [Related]
2. The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
Mieszczak J; Lowe ES; Plourde P; Eugster EA
J Clin Endocrinol Metab; 2008 Jul; 93(7):2751-4. PubMed ID: 18397987
[TBL] [Abstract][Full Text] [Related]
3. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
[TBL] [Abstract][Full Text] [Related]
4. Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome.
Feuillan PP; Jones J; Cutler GB
J Clin Endocrinol Metab; 1993 Sep; 77(3):647-51. PubMed ID: 8370686
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and management of precocious puberty in atypical presentations of McCune-Albright syndrome: a case series review.
Bercaw-Pratt JL; Moorjani TP; Santos XM; Karaviti L; Dietrich JE
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):e9-e13. PubMed ID: 22051789
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.
Estrada A; Boyce AM; Brillante BA; Guthrie LC; Gafni RI; Collins MT
Eur J Endocrinol; 2016 Nov; 175(5):477-483. PubMed ID: 27562402
[TBL] [Abstract][Full Text] [Related]
7. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
[TBL] [Abstract][Full Text] [Related]
8. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.
Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB
J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519
[TBL] [Abstract][Full Text] [Related]
9. Ovarian function in girls with McCune-Albright syndrome.
Foster CM; Feuillan P; Padmanabhan V; Pescovitz OH; Beitins IZ; Comite F; Shawker TH; Loriaux DL; Cutler GB
Pediatr Res; 1986 Sep; 20(9):859-63. PubMed ID: 3092175
[TBL] [Abstract][Full Text] [Related]
10. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
[TBL] [Abstract][Full Text] [Related]
11. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome.
Foster CM; Ross JL; Shawker T; Pescovitz OH; Loriaux DL; Cutler GB; Comite F
J Clin Endocrinol Metab; 1984 Jun; 58(6):1161-5. PubMed ID: 6427261
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of letrozole in treatment of McCune-Albright syndrome girls with peripheral precocious puberty].
Xu D; Lu W; Wang X; Wang J; Xie Y; Dong Z; Wang W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):291-296. PubMed ID: 32762164
[TBL] [Abstract][Full Text] [Related]
13. Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
Alves C; Silva SF
J Pediatr Endocrinol Metab; 2012; 25(3-4):323-5. PubMed ID: 22774233
[TBL] [Abstract][Full Text] [Related]
14. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
Roth C; Freiberg C; Zappel H; Albers N
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():945-8. PubMed ID: 12199354
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen improved final height prediction in a girl with McCune-Albright syndrome: patient report and literature review.
Sawathiparnich P; Osuwanaratana P; Santiprabhob J; Likitmaskul S
J Pediatr Endocrinol Metab; 2006 Jan; 19(1):81-6. PubMed ID: 16509532
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.
Eugster EA; Rubin SD; Reiter EO; Plourde P; Jou HC; Pescovitz OH;
J Pediatr; 2003 Jul; 143(1):60-6. PubMed ID: 12915825
[TBL] [Abstract][Full Text] [Related]
17. McCune-Albright syndrome (MAS): early and extensive bone fibrous dysplasia involvement and "mistaken identity" oophorectomy.
Gucev Z; Tasic V; Jancevska A; Krstevska-Konstantinova M; Pop-Jordanova N
J Pediatr Endocrinol Metab; 2010 Aug; 23(8):837-42. PubMed ID: 21073128
[TBL] [Abstract][Full Text] [Related]
18. Ketoconazole treatment of gonadotropin independent precocious puberty in girls with McCune-Albright syndrome: a preliminary report.
Syed FA; Chalew SA
J Pediatr Endocrinol Metab; 1999; 12(1):81-3. PubMed ID: 10392352
[TBL] [Abstract][Full Text] [Related]
19. Pubertal development in patients with McCune-Albright syndrome or pseudohypoparathyroidism.
de Sanctis C; Lala R; Matarazzo P; Andreo M; de Sanctis L
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():293-6. PubMed ID: 12729407
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen treatment of progressive precocious puberty in a patient with McCune-Albright syndrome.
Eugster EA; Shankar R; Feezle LK; Pescovitz OH
J Pediatr Endocrinol Metab; 1999; 12(5):681-6. PubMed ID: 10703542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
